REVB icon

Revelation Biosciences
REVB

13 hedge funds and large institutions have $984K invested in Revelation Biosciences in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$436K
2
+$388K
3
+$59.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$57.4K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$37.2K

Top Sellers

1
-$110K
2
-$21K
3
-$758
4
Citigroup
Citigroup
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$484K
AC
2
Armistice Capital
New York
$347K
Citadel Advisors
3
Citadel Advisors
Florida
$43.8K
Vanguard Group
4
Vanguard Group
Pennsylvania
$42K
Geode Capital Management
5
Geode Capital Management
Massachusetts
$27.2K
Northern Trust
6
Northern Trust
Illinois
$17.5K
HF
7
HRT Financial
New York
$12K
XT
8
XTX Topco
Cayman Islands
$9.05K
UBS Group
9
UBS Group
Switzerland
$579
SS
10
SBI Securities
Japan
$366
Bank of America
11
Bank of America
North Carolina
$38
DB
12
Danske Bank
Denmark
$1
DS
13
DRW Securities
Illinois
–
Jane Street
14
Jane Street
New York
–
TRCT
15
Tower Research Capital (TRC)
New York
–
Citigroup
16
Citigroup
New York
–
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
–
BNP Paribas Asset Management
18
BNP Paribas Asset Management
France
–